# Fresenius Kabi Compounding, LLC – FDA Inspection, Mar 6, 2023

Source: https://www.keypedia.com/records/fda_inspections/fresenius-kabi-compounding-llc/4d241940-c6c4-4b9b-b1e0-2366d2e3a4bb
Source feed: FDA_Inspections

> FDA inspection 1201601 of Fresenius Kabi Compounding, LLC, March 06, 2023. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1201601
- Company Name: Fresenius Kabi Compounding, LLC
- Inspection Date: 2023-03-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1290368 - 2025-11-05](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-compounding-llc/1d24adc1-59f9-4325-8055-4af95ddacd37)
- [FDA Inspection 1074214 - 2018-12-04](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-compounding-llc/ce034b7f-9876-47d3-84c4-a4cd15a8b819)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jonathan-g-matrisciano/17e5bce2-75a6-4182-925d-b94b42763dd2)

Company: https://www.keypedia.com/companies/fresenius-kabi-compounding-llc/2540f494-15fd-44ca-a889-e238f34ba9fd

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
